Amsterdam/Düsseldorf, 19 December 2023 –  Holland Capital invests in German company Honic for further development of their medical data platform.

Using this funding, Honic is able to further roll out its medical data platform. The platform – developed in cooperation with the German privacy regulator and various patient groups – is live since early 2022. The first research projects with universities and international life science companies have already been successfully conducted and completed. In cooperation with renowned partners such as Bundesdruckerei as data handler, IT security company Secunet, and Schwarz Group’s cloud provider StackIT, Honic offers a completely independent solution with its data platform.

Holland Capital led this funding round. Existing investors such as Dieter von Holtzbrinck Ventures, adesso Ventures and Isartal Ventures also participated in this round.

“In recent months, we have shown that the Honic platform is capable of making routinely collected medical data from routine care available for further research. With Holland Capital’s investment, we will further expand the Honic data infrastructure and unlock new data sources to play a pivotal role in the emerging European Health Data Space (EHDS),” said dr. Henrik Matthies, CEO and co-founder of Honic.

“Honic is unique in the European health tech scene as it has been able to develop a data infrastructure aligned with the privacy regulator that can enable large-scale, interdisciplinary medical research. This enables medical research using routinely collected data which is aggregated from different sources . We are delighted to be involved in the next phase of Honic,” said Jan-Frens van Giessel, partner at Holland Capital.

“Holland Capital reinforces Honic’s mission to expand medical science in Germany and Europe. In addition to its financial investment, Holland Capital’s team also supports us with their vast experience and expertise. I am very pleased that we were able to attract international experts such as Harm-Jan Wessels and Achim Plückebaum for the board of Honic,” said Prof. med Jörg F. Debatin, MBA, chairman of the board and co-founder of Honic.

About Honic

Honic was founded by dr. Henrik Matthies and prof. dr. med J. F. Debatin, MBA. The platform, developed in cooperation with the privacy regulator in Germany, uses a unique concept allowing anonymized medical data to be aggregated to generate “Real World” insights for medical research. Since 2022, the platform has been live and successful research projects with universities and international life science companies have been conducted.

About Holland Capital

Over the past 40 years Holland Capital has invested responsibly and successfully in more than 180 Dutch SMEs. With a clear investment strategy it is active in the attractive growth markets Healthcare, Technology and Agrifood. The experienced and committed investment team knows what entrepreneurship is all about. It aims for an open, sustainable and professional relationship with the management teams of the companies it invests in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs and has offices in Amsterdam and Düsseldorf.